Jeil Pharma Holdings (XKRX:002620) Construction In Progress : ₩4,060 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Construction In Progress?

Jeil Pharma Holdings's quarterly construction in progress declined from Sep. 2023 (₩3,277 Mil) to Dec. 2023 (₩3,269 Mil) but then increased from Dec. 2023 (₩3,269 Mil) to Mar. 2024 (₩4,060 Mil).

Jeil Pharma Holdings's annual construction in progress declined from Dec. 2021 (₩11,778 Mil) to Dec. 2022 (₩3,851 Mil) and declined from Dec. 2022 (₩3,851 Mil) to Dec. 2023 (₩3,269 Mil).

Jeil Pharma Holdings Construction In Progress Historical Data

The historical data trend for Jeil Pharma Holdings's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Construction In Progress Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

760.76

7,583.10

11,778.33

3,850.87

3,268.67

Jeil Pharma Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															3,053.78	2,955.58	3,277.03	3,268.67	4,059.95

Jeil Pharma Holdings Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines